Search In this Thesis
   Search In this Thesis  
العنوان
EFFECT OF LOSARTAN TREATMENT ON LIVER FIBROSIS OF CHRONIC HCV PATIENTS/
الناشر
Shereif Ahmed Morsy،
المؤلف
Shereif Ahmed ،Morsy
هيئة الاعداد
باحث / Shereif Ahmed ،Morsy
مشرف / Zakaria ،A. Salama.,
مشرف / Gamal Eldin ،Esmat.
مشرف / Ahmed ،M. Abdelhady.
تاريخ النشر
2010.
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
الصحة العامة والصحة البيئية والمهنية
تاريخ الإجازة
1/1/2010
مكان الإجازة
جامعة القاهرة - كلية الطب - طب المناطق الحارة وصحتها
الفهرس
Only 14 pages are availabe for public view

from 142

from 142

Abstract

The discovery of the hepatitis C genome in 1989 has led to the realization that this virus is a major worldwide health problem (Alter et al, 1999). The hepatitis C virus (HCV) is one of the most common causes of chronic liver disease and a leading indication for liver transplantation. There are 170 million individuals infected worldwide. Approximately 20% of these individuals will progress to develop cirrhosis over the following 20 years. Death occurs at a rate of 2% to 5% per year once the patient develops cirrhosis and the risk of developing hepatocellular carcinoma (HCC) is 3% to 7% per year after the development of cirrhosis. Overall